Navigation Links
Dr. Richard Feinman to speak on the science of diabetes and diet on Oct. 2
Date:9/28/2009

Richard Feinman, PhD, professor of biochemistry and of family medicine at SUNY Downstate Medical Center in Brooklyn, New York, will speak at the annual conference of the European Association for the Study of Diabetes (EASD) on October 2, 2009. EASD is holding its annual conference September 28 October 2 in Vienna, Austria.

Dr. Feinman will be one of four speakers covering the topic, Controversies in Dietary Strategies in the Treatment of Diabetes.

According to Dr. Feinman, it has been scientifically documented that carbohydrate consumption raises blood glucose and there is no disagreement that diabetes is a disease of carbohydrate intolerance. "There really is no controversy about the science," Dr. Feinman explains. "It's as simple as this: An increase in dietary carbohydrate will raise HbA1c, which in turn will raise the risk of microvascular complications, and this is science we all agree on."

"That being said," he adds, "the controversy may indeed be whether or not we are getting good advice from our healthcare professionals, but that is out of my area I will be at the conference in Vienna to explain the science."

Dr. Feinman's presentation will take place at the Messe Wien in van Swieten Hall on October 2, 2009.


'/>"/>

Contact: Richard Feinman
Richard.Feinman@downstate.edu
718-270-2252
SUNY Downstate Medical Center
Source:Eurekalert

Page: 1

Related biology news :

1. Aware, Inc. Announces Richard Moberg to Return as CFO
2. PNNLs Richard Smith named to prestigious Scientific American 50 list of outstanding leaders
3. AGU Journalism Awards won by Margaret Munro and Dr. Richard Smith
4. Brupbacher prize to Nubia Munoz and Sir Richard Peto
5. Jonathan Berg, M.D., Ph.D. awarded Richard King Trainee Award for Best in Genetics in Medicine
6. American Society for Microbiology honors Richard W. Castenholz
7. Office of the Director of National Intelligence, CIO to Speak at Government Security Conference
8. Director of National Intelligence to Speak at Conference
9. Office of the Director of National Intelligence, CIO to Speak at Government Security Conference
10. Director of National Intelligence to Speak at Conference
11. Computer learns dogspeak
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/6/2017)... -- Forecasts by Product Type (EAC), Biometrics, ... (Transportation & Logistics, Government & Public Sector, Utilities / ... Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), Hospitality ... looking for a definitive report on the $27.9bn Access ... ...
(Date:4/4/2017)... NEW YORK , April 4, 2017   ... solutions, today announced that the United States Patent and ... The patent broadly covers the linking of an iris ... the same transaction) and represents the company,s 45 th ... our latest patent is very timely given the multi-modal ...
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities ... (physiological and behavioral), by technology (fingerprint, AFIS, iris recognition, ... recognition, and others), by end use industry (government and ... immigration, financial and banking, and others), and by region ... , Asia Pacific , and ...
Breaking Biology News(10 mins):
(Date:4/20/2017)... ... April 20, 2017 , ... NetDimensions appoints Bill Mastin, a learning technology veteran, ... of experience in the learning technologies industry, Mastin joins NetDimensions from the New York ... plc (LTG). At LEO, Mastin served as SVP of the North America offices and ...
(Date:4/20/2017)... (PRWEB) , ... April 20, 2017 , ... ... formation of a unique intellectual property (IP) sharing and commercialization model. , The ... promising inventions. A main component of this effort is bringing the IP to ...
(Date:4/19/2017)... ... ... The Vibrating Orifice Aerosol Generator (VOAG) was developed in ... known diameters for research applications such as for calibrating droplet measuring instruments, for ... , The VOAG requires forcing liquid out of an orifice about half ...
(Date:4/19/2017)... , ... April 19, 2017 , ... Nobilis Therapeutics ... , Company Seeks to Leverage Clinical Data in its Upcoming Post Traumatic Stress Disorder ... of an 81 patient clinical trial assessing efficacy of its NBTX-001, a xenon-based therapeutic ...
Breaking Biology Technology: